ONY Biotech

A small, privately-held, and family-focused neonatology pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. We innovate with a singular purpose: to improve outcomes for premature babies and their families. As a USA-born neonatology biotech, we take pride in the work we do delivering treatments that serve families here in the United States and around the world. Behind ONY Biotech is a focused team with decades of biotechnology and pharmaceutical industry experience. Founded in 1985 by neonatologist Dr. Edmund Egan, a professor of pediatrics at the State University of New York at Buffalo, ONY Biotech has a proven track record of bringing innovative neonatal therapies for unmet medical needs to market.